Does FOSAPREPITANT DIMEGLUMINE Cause Obesity? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Obesity have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 2.5% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.
22
Reports of Obesity with FOSAPREPITANT DIMEGLUMINE
2.5%
of all FOSAPREPITANT DIMEGLUMINE reports
22
Deaths
22
Hospitalizations
How Dangerous Is Obesity From FOSAPREPITANT DIMEGLUMINE?
Of the 22 reports, 22 (100.0%) resulted in death, 22 (100.0%) required hospitalization, and 22 (100.0%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?
Dyspnoea (142)
Pyrexia (136)
Nausea (130)
Infusion related reaction (83)
Diarrhoea (80)
Vomiting (71)
Rash (66)
Hypersensitivity (65)
Stomatitis (64)
Decreased appetite (62)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Obesity Risk?
FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT DIMEGLUMINE vs FOSCARNET
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE
FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL